Tendinitis Clinical Trials

Find Tendinitis Clinical Trials Near You

Platelet Rich Plasma for Musculoskeletal Conditions

Status: Recruiting
Location: See location...
Intervention Type: Biological, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• 18+ years old

• Musculoskeletal pathology that may benefit from a PRP injection

• Failed other conservative treatments

Locations
United States
Utah
University of Utah Orthoaedic Center
RECRUITING
Salt Lake City
Contact Information
Primary
Luke A Johnson, BS
luke.a.johnson@hsc.utah.edu
18012133379
Backup
Jamie Egbert, MS
jamie.egbert@utah.edu
Time Frame
Start Date: 2025-12-29
Estimated Completion Date: 2035-01-01
Participants
Target number of participants: 10000
Treatments
Experimental: Platelet Rich Plasma Injection
Participants who are eligible and provide consent to participate will undergo a Platelet-Rich Plasma (PRP) injection. Their whole blood and the produced PRP will be analyzed using a cell counter, and they will be asked to complete follow-up surveys at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months..
Related Therapeutic Areas
Sponsors
Leads: University of Utah

This content was sourced from clinicaltrials.gov